Bioresorbable Embolization Microspheres

The present disclosure is generally directed to an embolic material which is in the form of a microsphere or a plurality of microspheres. The embolic material generally comprises carboxymethyl chitosan (CCN) crosslinked with carboxymethyl cellulose (CMC). In some embodiments, the embolic material may further comprise a therapeutic agent, such as doxorubicin.

Attached files:


Patents:
WO 2,011,044,236

Inventor(s): WENG LIHUI [US]; GOLZARIAN JAFAR [US]

Type of Offer: Licensing



« More Medical Patents

---